 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
GLYCOGENESYS INC, (GLGS) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The companys lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It has also developed agricultural products, which are also based upon carbohydrate chemistries. The company was co-founded by David Platt in 1992 as IGG International, Inc. It changed its name to SafeScience, Inc. in 1998 and further changed its name to GlycoGenesys, Inc. in 2001. The company is based in Boston, Massachusetts.
|
GLYCOGENESYS INC Related |
|
GlycoGenesys, Inc. GlycoGenesys commenced operations in 1993 as IGG International, Inc. ... that year, the Company took its present name, GlycoGenesys, Inc. ...
|
|
GLGSQ.PK: Summary for GLYCOGENESYS INC - Yahoo! Finance Get detailed information on GLYCOGENESYS INC (GLGSQ.PK) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and ...
|
|
GLGS: Summary for GLYCOGENESYS INC - Yahoo! Finance Get detailed information on GLYCOGENESYS INC (GLGS) including quote performance, ... On Feb 6: 0.16 0.00 (0.00%) GLYCOGENESYS INC (GLGS) More On GLGS. Quotes. Summary ...
|
|
|
|
|
